Royalty Pharma plc Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2020 to Q4 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Royalty Pharma plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q4 2024.
- Royalty Pharma plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 594M shares, a 1.46% decline year-over-year.
- Royalty Pharma plc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 594M shares, a 1.46% decline from 2023.
- Royalty Pharma plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 603M shares, a 37.7% increase from 2022.
- Royalty Pharma plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 438M shares, a 5.59% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)